MedTrace Logo

Comparison of Chlorpromazine or Pentobarbital Premedications for Pediatric Imaging Procedures

NCT04350528 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 254

Last updated 2020-04-17

No results posted yet for this study

Summary

Sedation is often required for pediatric medical imaging procedures to ensure compliance and quality images. Recommendations exist regarding pediatric sedation, but there are currently no guidelines regarding the choice of the sedative drug. We aim to compare the efficacy and adverse events of per os pentobarbital with intravenous chlorpromazine in children undergoing diagnostic imaging procedures.

Conditions

  • Children Sedation

Interventions

DRUG

Chlorpromazine or Pentobarbital

Sedation

Sponsors & Collaborators

  • University Hospital, Brest

    lead OTHER

Principal Investigators

  • Juliette Ropars, MD · Brest University Hospital in France

Eligibility

Min Age
6 Months
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-30
Primary Completion
2020-06-30
Completion
2020-06-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04350528 on ClinicalTrials.gov